Download presentation
Presentation is loading. Please wait.
Published byCalvin Lawrence Modified over 8 years ago
1
Aggressive Therapy of Hypercholesterolemia in Acute Coronary Syndromes Timothy A. Denton, M.D. Divisions of Cardiology and Cardiothoracic Surgery Cedars-Sinai Medical Center, Los Angeles, CA California Chairman, AHA "Get with the Guidelines"
2
Who are we talking about? Known vascular disease CAD Carotid PVD Aortic Aneurysm Vascular equivalents DM High risk 10 year risk > 20% NCEP III -- JAMA 2000;285:2486
3
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories 190 (160–189: LDL- lowering drug optional) 160 <160 0–1 Risk Factor 10-year risk 10–20%: 130 10-year risk <10%: 160 130 <130 2+ Risk Factors (10-year risk 20%) 130 (100–129: drug optional) 100 <100 CHD or CHD Risk Equivalents (10-year risk >20%) LDL Level at Which to Consider Drug Therapy (mg/dL) LDL Level at Which to Initiate Therapeutic Lifestyle Changes (TLC) (mg/dL) LDL Goal (mg/dL) Risk Category
4
1 - Diet 2 - Exercise 3 - Drugs 4 - Partial ileal bypass 5 - Portacaval shunting 6 - Apheresis adsorption column (LDL apheresis) plasma exchange double membrane dextran sulfate precipitation immunoabsorption 7 - Liver transplantation Methods for Modifying Cholesterol Levels
5
Atherosclerosis
6
Egg McMuffin Calories290 Calories from fat110 Total fat12 g Saturated fat4.5 g Cholesterol235 mg Sodium790 mg Carbohydrates27g Protein17g http://www.mcdonalds.com/countries/usa/
7
Ornish D, et al. Lancet 1990;336:129 Lifestyle Heart Trial
8
Ornish D, et al. Lancet 1990;336:129 Lifestyle Heart Trial
9
Ornish D, et al. Lancet 1990;336:129 Lifestyle Heart Trial Intervention group LDL after 1 year Mean = 93 mg/dl + 43 mg/dl NCEP Goal 55.3% 44.7%
10
Mediterranian Diet J. THOMSON "Chart of the Mediterranean Sea" Edin.18I7
11
Lyon Heart Trial De Lorgeril et al Circulation 1999;99:779 First MI Randomized Mediterranian vs Prudent 5 year trial stopped early <35% energy as fat <10% energy saturated fat <4% energy as linoleic acid >0.6% of energy as alpha-linolenic (18:3 or n-3) Eat more bread Eat more fish, less meat Eat more vegetables Must have fruit every day All butter and margarine replaced with olive oil and canola oil
12
Lyon Heart Trial De Lorgeril et al Circulation 1999;99:779 Survival with: No MI Survival with: No MI Angina CHF CVA PE Periph embol Survival with: No MI Angina CHF CVA PE Periph embol Stable angina PTCA, CABG Restenosis
13
Lyon Heart Trial De Lorgeril et al Circulation 1999;99:779 Differences in LDL-C
14
1. Disease-specific Renal Diabetes 2.Weight loss Thousands 3.Lipid management Hundreds 4.Survival Mediterranian Fish Goals of Diet(s)
15
Exercise
16
Myers, NEJM 2002;346:793 6,213 men ETT for clinical reasons 2,534 normal 3,679 with CAD Mean f/u 6.2 years Age 59 + 11 Peak capacity stronger predictor than cigs, HTN, DM, Chol
17
Effect of Exercise on Lipids Kokkinos Arch Int Med 1995:155:415 2906 men age 30-64 years exercise treadmill test to exhaustion classified into 6 groups based on average miles run per week
18
Effect of Exercise on Lipids Kokkinos Arch Int Med 1995:155:415
19
Cholesterol-Lowering Drugs
20
Cholesterol Modifying Agents
21
4S
22
Summary of Key End-points Simvastatin vs. placebo Total mortality CAD mortality Major coronary events PTCA/CABG Event-freesurvival 0.20.40.60.81.01.2 p=0.0003 p<0.00001 Relative risk (95% CI) ReducedIncreased
23
Effects of Statin on Total Mortality (4S) Diabetics (n= 201) vs Non-Diabetics (n=4242) 43% risk reduction 28% risk reduction Presented at the ACC Meeting March 19-22, 1995
24
When should we START therapy?
25
MIRACL P=0.048 Schwartz JAMA 2001;285:1711
26
CHAMP Fonarow, AJC 2001;87:819
27
CHAMP
28
When should we START therapy? AS SOON AS POSSIBLE!!!!
29
Why start drugs in the Hospital? Use diet and exercise on all patients, wait 3-6 months for statin therapy: 4% will have LDL < 100 mg/dL Start statin in the hospital, recommend diet and exercise: 96% get needed therapy 4% "overtreated"
30
How do you improve your rate of therapy?
31
Improving Process of Care Finding a "Champion" Develop a team Baseline measurement Use the team to develop new processes pocket reminders standard orders computer reminders Follow-up measurement
32
Clinician Checklist
33
Patient Checklist
35
Get With the Guidelines!
36
The Guidelines
37
How often do we provide these therapies?
38
State Standings Jencks et al. JAMA 2000;284:1670 Ranked by CV indicators, mammog, immune, etc
39
What is the GWTG Plan? Hospitals Medical Groups Kaiser Tenet CHCW Large payors Government Educational programs Tools Carrots Sticks Everything still in development
40
Management of MedRx On transfer out of the ICU ABC 2 D aspirin beta blocker cholesterol agent converting enzyme inhibitor (ACE) diabetes On the ward hypertension therapy smoking cessation BMI recommendations exercise recommendations
41
All CABG-only, 10/1/2001 to 12/31/2001 compare to 1999 data CSMC Cardiothoracic Surgery
42
Effects of Various Cardiac Therapies
45
Why should you do this? JCAHO Oryx HEDIS Marketing I swear by Apollo the physician, by Aesculapius, Hygeia, and Panacea, and take to witness all the gods, all the goddesses to keep according to my ability and my judgement the following oath:...
46
End
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.